Cargando…

Corrigendum: A cohort-based case report: The impact of ketamine-assisted therapy embedded in a community of practice framework for healthcare providers with PTSD and depression

Detalles Bibliográficos
Autores principales:	Dames, Shannon, Kryskow, Pamela, Watler, Crosbie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9344338/ https://www.ncbi.nlm.nih.gov/pubmed/35928772 http://dx.doi.org/10.3389/fpsyt.2022.962882

Ejemplares similares

A Cohort-Based Case Report: The Impact of Ketamine-Assisted Therapy Embedded in a Community of Practice Framework for Healthcare Providers With PTSD and Depression
por: Dames, Shannon, et al.
Publicado: (2022)

Safety and tolerability of intramuscular and sublingual ketamine for psychiatric treatment in the Roots To Thrive ketamine-assisted therapy program: a retrospective chart review
por: Tsang, Vivian W.L., et al.
Publicado: (2023)

Safety and Tolerability of Intramuscular and Sublingual Ketamine for Psychiatric Treatment in the Roots to Thrive Ketamine Assisted Therapy Program
por: Tsang, V. W. L., et al.
Publicado: (2023)

The Montreal model: an integrative biomedical-psychedelic approach to ketamine for severe treatment-resistant depression
por: Garel, Nicolas, et al.
Publicado: (2023)

The Multivariate Effect of Ketamine on PTSD: Systematic Review and Meta-Analysis
por: Du, Rui, et al.
Publicado: (2022)

A Pilot Study Comparing a Community of Practice Group Therapy Program with and without Concurrent Ketamine-assisted Therapy
por: Tsang, V. W. L., et al.
Publicado: (2023)

Psychological Interventions for Healthcare Providers With PTSD in Life-Threatening Pandemic: Systematic Review and Meta-Analysis
por: Sun, Zeyuan, et al.
Publicado: (2021)

Epigenetic Risk Factors in PTSD and Depression
por: Raabe, Florian Joachim, et al.
Publicado: (2013)

Subcutaneous Ketamine in Depression: A Systematic Review
por: Cavenaghi, Vitor Breseghello, et al.
Publicado: (2021)

Ketamine-assisted psychotherapy in adolescents with multiple psychiatric diagnoses
por: Wolfson, Philip E., et al.
Publicado: (2023)

Investigating post-traumatic stress disorder (PTSD) and complex PTSD among people with self-reported depressive symptoms
por: Fung, Hong Wang, et al.
Publicado: (2022)

The Effect of Ketamine on Electrophysiological Connectivity in Major Depressive Disorder
por: Nugent, Allison C., et al.
Publicado: (2020)

Ketamine for Bipolar Depression: Biochemical, Psychotherapeutic, and Psychedelic Approaches
por: Bennett, Raquel, et al.
Publicado: (2022)

Vulnerability and Protective Factors for PTSD and Depression Symptoms Among Healthcare Workers During COVID-19: A Machine Learning Approach
por: Portugal, Liana C. L., et al.
Publicado: (2022)

Ketamine study: Protocol for naturalistic prospective multicenter study on subcutaneous ketamine infusion in depressed patients with active suicidal ideation
por: Anzolin, Ana Paula, et al.
Publicado: (2023)

MDMA-assisted therapy is associated with a reduction in chronic pain among people with post-traumatic stress disorder
por: Christie, Devon, et al.
Publicado: (2022)

Reduction of Posttraumatic Stress Disorder (PTSD) Symptoms in PTSD and Major Depressive Disorder Comorbidity After Acute Hypoglycemia—A Case Report
por: Pawlowski, Tomasz, et al.
Publicado: (2019)

From War to Classroom: PTSD and Depression in Formerly Abducted Youth in Uganda
por: Winkler, Nina, et al.
Publicado: (2015)

Antianhedonic Effect of Repeated Ketamine Infusions in Patients With Treatment Resistant Depression
por: Wilkowska, Alina, et al.
Publicado: (2021)

Gender differences in the antianhedonic effects of repeated ketamine infusions in patients with depression
por: Zheng, Wei, et al.
Publicado: (2022)

Hippocampal subfield volumes in treatment resistant depression and serial ketamine treatment
por: Zavaliangos-Petropulu, Artemis, et al.
Publicado: (2023)

Depression and/or PTSD Comorbidity Affects Response to Antidepressants in Those With Alcohol Use Disorder
por: Na, Peter J., et al.
Publicado: (2022)

Neural and Behavioral Correlates of Clinical Improvement to Ketamine in Adolescents With Treatment Resistant Depression
por: Thai, Michelle, et al.
Publicado: (2020)

Plasma VEGF Concentrations and Ketamine's Effects on Suicidal Ideation in Depression With Suicidal Ideation
por: Zheng, Wei, et al.
Publicado: (2022)

Pre-treatment Pain Symptoms Influence Antidepressant Response to Ketamine in Depressive Patients
por: Lan, Xiaofeng, et al.
Publicado: (2022)

Healthcare Workers and COVID-19-Related Moral Injury: An Interpersonally-Focused Approach Informed by PTSD
por: D'Alessandro, Andrea M., et al.
Publicado: (2022)

MDMA-assisted psychotherapy; Inclusion of transgender and gender diverse people in the frontiers of PTSD treatment trials
por: Stauffer, Christopher S., et al.
Publicado: (2022)

Corrigendum: Outcome Evaluation of a Short-Term Hospitalization and Community Support Program for People Who Abuse Ketamine
Publicado: (2019)

Corrigendum: Initial development of perpetrator confrontation using deepfake technology in victims with sexual violence-related PTSD and moral injury
por: van Minnen, Agnes, et al.
Publicado: (2023)

Depression, Estrogens, and Neuroinflammation: A Preclinical Review of Ketamine Treatment for Mood Disorders in Women
por: Gagne, Collin, et al.
Publicado: (2022)

Association of VEGF With Antianhedonic Effects of Repeated-Dose Intravenous Ketamine in Treatment-Refractory Depression
por: Zheng, Wei, et al.
Publicado: (2021)

A comparison of the antianhedonic effects of repeated ketamine infusions in melancholic and non-melancholic depression
por: Zheng, Wei, et al.
Publicado: (2022)

The Efficacy of Psychedelic-Assisted Therapy in Managing Post-traumatic Stress Disorder (PTSD): A New Frontier?
por: Mohamed, Arafath, et al.
Publicado: (2022)

Corrigendum: Risk Perception and PTSD Symptoms of Medical Staff Combating Against COVID-19: A PLS Structural Equation Model
por: Yin, Qianlan, et al.
Publicado: (2022)

Reductions in anxiety and depression symptoms in a subset of outpatients with problematic substance use who received ketamine-assisted psychotherapy: a two-year retrospective chart review
por: Whinkin, Emily, et al.
Publicado: (2023)

Intravenous ketamine for depression: A clinical discussion reconsidering best practices in acute hypertension management
por: Yip, Ryan, et al.
Publicado: (2022)

Case Report: Unexpected Remission From Extreme and Enduring Bulimia Nervosa With Repeated Ketamine Assisted Psychotherapy
por: Ragnhildstveit, Anya, et al.
Publicado: (2021)

A proposed mechanism for the MDMA-mediated extinction of traumatic memories in PTSD patients treated with MDMA-assisted therapy
por: Sottile, Robert J., et al.
Publicado: (2022)

Craving for Ketamine and Its Relationship With Clinical Outcome Indicators in Males With Ketamine Use Disorder
por: Wang, Peng-Wei, et al.
Publicado: (2021)

Metabolomics Analysis on Mice With Depression Ameliorated by Acupoint Catgut Embedding
por: Duan, Lining, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0i84nhelc4pdiqc8ou6mhfrig9